We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+7.09%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.8B
AUM Growth
+$1.26B
(+2.4%)
Cap. Flow
-$756M
Cap. Flow
% of AUM
-1.41%
Top 10 Holdings %
Top 10 Hldgs %
12.51%
Holding
2,394
New
190
Increased
762
Reduced
1,027
Closed
198
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$173M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
+$143M |
| 3 |
Blue Owl Capital
OWL
|
+$142M |
| 4 |
Conagra Brands
CAG
|
+$136M |
| 5 |
Lockheed Martin
LMT
|
+$107M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$215M |
| 2 |
PepsiCo
PEP
|
+$200M |
| 3 |
IBM
IBM
|
+$181M |
| 4 |
Merck
MRK
|
+$123M |
| 5 |
TSMC
TSM
|
+$118M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.62% |
| 2 | Technology | 19.5% |
| 3 | Financials | 11.8% |
| 4 | Consumer Discretionary | 8.89% |
| 5 | Industrials | 8.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Resideo Technologies
REZI
$2.83B
| $4.73M | 0.01% |
181,724
-294,250
| -62% | -$7.63M |
|
|
OZON
827
DELISTED
Ozon Holdings PLC American Depositary Shares, each ADS representing one ordinary share
OZON
| $4.69M | 0.01% |
158,518
+52,161
| +49% | +$2.15M |
|
828
Nutanix
NTNX
$18.6B
| $4.68M | 0.01% |
146,838
-328,287
| -69% | -$11.3M |
|
829
Xencor
XNCR
$1.76B
| $4.67M | 0.01% |
116,459
-38,600
| -25% | -$1.46M |
|
830
Levi Strauss
LEVI
$7.56B
| $4.67M | 0.01% |
186,538
-516,353
| -73% | -$13.3M |
|
831
Groupon
GRPN
$786M
| $4.64M | 0.01% |
200,354
+78,653
| +65% | +$1.84M |
|
832
AMC Entertainment Holdings
AMC
$2.37B
| $4.63M | 0.01% |
17,032
+3,287
| +24% | +$1.16M |
|
833
Becton Dickinson
BDX
$49.5B
| $4.6M | 0.01% |
18,750
+1,288
| +7% | +$309K |
|
|
DBD
834
DELISTED
Diebold Nixdorf Incorporated
DBD
| $4.6M | 0.01% |
508,355
+43,415
| +9% | +$404K |
|
835
Akebia Therapeutics
AKBA
$254M
| $4.6M | 0.01% |
2,034,347
+5,244
| +0.3% | +$14.3K |
|
|
MRC
836
DELISTED
MRC Global
MRC
| $4.6M | 0.01% |
668,193
+33,691
| +5% | +$264K |
|
837
Bread Financial
BFH
$4.14B
| $4.58M | 0.01% |
68,748
-22,364
| -25% | -$1.65M |
|
838
Zevia
ZVIA
$95.9M
| $4.56M | 0.01% |
647,400
-15,000
| -2% | -$146K |
|
839
Kite Realty
KRG
$5.14B
| $4.56M | 0.01% |
209,237
+130,086
| +164% | +$2.78M |
|
840
Halliburton
HAL
$28.8B
| $4.54M | 0.01% |
198,470
+762
| +0.4% | +$18K |
|
|
MOLN
841
Molecular Partners
MOLN
$161M
| $4.54M | 0.01% |
235,294
| – | – |
|
|
DADA
842
DELISTED
Dada Nexus
DADA
| $4.53M | 0.01% |
344,118
+88,081
| +34% | +$1.7M |
|
843
Smartbird Inc
BIRD
$28M
| $4.52M | 0.01% |
+15,000
| New | +$5.62M |
|
|
ITOS
844
DELISTED
iTeos Therapeutics
ITOS
| $4.46M | 0.01% |
+95,798
| New | +$3.19M |
|
|
CPRX
845
DELISTED
Catalyst Pharmaceutical
CPRX
| $4.45M | 0.01% |
657,454
+215
| +0% | +$1.41K |
|
846
Progyny
PGNY
$2.1B
| $4.43M | 0.01% |
88,024
-316,489
| -78% | -$17.7M |
|
847
Hancock Whitney
HWC
$5.98B
| $4.41M | 0.01% |
88,181
+1,636
| +2% | +$81.6K |
|
848
US Foods
USFD
$20B
| $4.4M | 0.01% |
+126,270
| New | +$4.39M |
|
849
NRG Energy
NRG
$22.6B
| $4.39M | 0.01% |
101,938
+3,221
| +3% | +$126K |
|
|
DHR.PRA
850
DELISTED
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
| $4.39M | 0.01% |
+2,000
| New | +$4.14M |
|
Similar funds
Federated Hermes's Q4 2021 Portfolio in Review
As of Q4 2021, Federated Hermes held 2,394 positions worth $53.8B, up 2.4% from $52.5B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Federated Hermes's Q4 2021 filing shows 190 new, 762 increased, 1,027 reduced and 198 closed positions. Its largest new stake was Conagra Brands: 4,144,058 shares worth $142M. The largest sale was Moderna, an estimated $215M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 22% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q4 2021 buy was Conagra Brands: 4,144,058 shares worth $142M.
- Federated Hermes added most to Bristol-Myers Squibb in Q4 2021, an estimated $173M increase.
- Federated Hermes's biggest Q4 2021 reduction was Moderna, cutting an estimated $215M.
- Federated Hermes fully exited GoDaddy in Q4 2021, selling an estimated $77.2M.
- Federated Hermes's ten largest holdings make up 13% of its $53.8B portfolio in Q4 2021.
- Federated Hermes opened 190 new positions and closed 198 in Q4 2021.
- Federated Hermes's portfolio value rose 2.4% quarter-over-quarter to $53.8B.
Based on Federated Hermes's 13F filing for Q4 2021, filed 14 Feb 2022.